Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#151 / 199 Total
SDIG - Stronghold Digital Mining Inc - Stock Price Chart
TickerSDIG [NASD]
CompanyStronghold Digital Mining Inc
CountryUSA
IndustryCapital Markets
Market Cap35.15MEPS (ttm)-3.00
P/E-EPS this Y88.87%
Forward P/E-EPS next Y6.02%
PEG-EPS past 5Y-68.53%
P/S0.41EPS next 5Y-
P/B0.56EPS Q/Q105.40%
Dividend-Sales Q/Q59.40%
Insider Own16.04%Inst Own16.80%
Insider Trans-15.28%Inst Trans2.73%
Short Float4.56%EarningsMay 02/b
Analyst Recom1.67Target Price7.17
Avg Volume508.74K52W Range1.65 - 11.56
May-06-24 10:25AM Stronghold Digital Mining, Inc. (NASDAQ:SDIG) Q1 2024 Earnings Call Transcript (Insider Monkey) -6.55%
May-03-24 03:54AM Stronghold Digital Mining Inc (SDIG) (Q1 2024) Earnings Call Transcript Highlights: Surpassing ... (GuruFocus.com)
01:12AM Q1 2024 Stronghold Digital Mining Inc Earnings Call (Thomson Reuters StreetEvents)
May-02-24 01:54PM SDIG Stock Earnings: Stronghold Digital Mining Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
09:48AM Stronghold Digitals Shares Jump With Bitcoin Miner Mulling Sale (Bloomberg)
09:02AM Bitcoin Miner Stronghold Looking at Options, Including Sale of Company (CoinDesk)
08:30AM Stronghold Announces First Quarter 2024 Operating and Financial Results (GlobeNewswire)
Apr-25-24 08:30AM Stronghold Announces Preliminary First Quarter 2024 Results (GlobeNewswire) +9.46%
Apr-09-24 08:30AM Stronghold Provides March 2024 Bitcoin Mining and Operational Update (GlobeNewswire)
Mar-31-24 08:19AM Insiders Are Dumping These 12 Financial Stocks (Insider Monkey)
LGCL - Lucas GC Ltd - Stock Price Chart
TickerLGCL [NASD]
CompanyLucas GC Ltd
CountryChina
IndustrySoftware - Application
Market Cap253.00MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own88.43%Inst Own0.29%
Insider Trans0.00%Inst Trans-
Short Float0.80%Earnings-
Analyst Recom-Target Price-
Avg Volume251.82K52W Range2.02 - 5.00
Apr-29-24 04:05PM Lucas Announces Fiscal Year 2023 Financial Results with 92.3% Growth, Reaching Revenue at $208M (GlobeNewswire) +5.16%
09:00AM Lucas To Discuss Fiscal Year 2023 Financial Results on April 29, 2024 After Market Close (GlobeNewswire)
Mar-07-24 11:43AM Lucas GC Limited Announces Closing of Initial Public Offering (PR Newswire) -15.67%
Mar-04-24 09:38PM Lucas GC Limited Announces Pricing of Upsized Initial Public Offering (PR Newswire)
ALUR - Allurion Technologies Inc - Stock Price Chart
TickerALUR [NYSE]
CompanyAllurion Technologies Inc
CountryUSA
IndustryMedical Devices
Market Cap84.87MEPS (ttm)-3.79
P/E-EPS this Y80.95%
Forward P/E-EPS next Y-4.55%
PEG-EPS past 5Y-
P/S1.74EPS next 5Y-
P/B-EPS Q/Q126.30%
Dividend-Sales Q/Q-
Insider Own24.13%Inst Own19.06%
Insider Trans0.00%Inst Trans-8.35%
Short Float1.45%EarningsMay 14/b
Analyst Recom1.00Target Price5.00
Avg Volume1.04M52W Range1.56 - 10.94
May-15-24 08:00AM Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss (Business Wire) -9.00%
May-14-24 12:53PM ALUR Stock Earnings: Allurion Technologies Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +8.76%
08:00AM Allurion Reports First Quarter 2024 Financial Results and Provides Business Update (Business Wire)
May-02-24 08:00AM Allurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey (Business Wire) -6.38%
Apr-30-24 08:30AM Allurion Announces Preliminary First Quarter 2024 Results (Business Wire)
Apr-17-24 08:31AM Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments (Business Wire) -8.05%
Apr-04-24 08:00AM Allurion Expands Virtual Care Suite to the United States (Business Wire) +78.03%
Mar-21-24 12:53PM ALUR Stock Earnings: Allurion Technologies Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace)
08:00AM Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance (Business Wire)
Mar-13-24 08:30AM Allurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference (Business Wire) +6.04%
NOTV - Inotiv Inc - Stock Price Chart
TickerNOTV [NASD]
CompanyInotiv Inc
CountryUSA
IndustryDiagnostics & Research
Market Cap50.12MEPS (ttm)-2.76
P/E-EPS this Y31.54%
Forward P/E-EPS next Y38.84%
PEG-EPS past 5Y-184.24%
P/S0.09EPS next 5Y-
P/B0.24EPS Q/Q-378.36%
Dividend-Sales Q/Q-21.41%
Insider Own10.83%Inst Own25.40%
Insider Trans2.20%Inst Trans-9.15%
Short Float4.89%EarningsMay 15/a
Analyst Recom2.33Target Price4.67
Avg Volume572.19K52W Range1.61 - 11.42
May-15-24 09:54PM NOTV Stock Earnings: Inotiv Misses EPS, Misses Revenue for Q2 2024 (InvestorPlace) +5.66%
04:05PM Inotiv Reports Second Quarter Financial Results for Fiscal 2024 and Provides Business Update (GlobeNewswire)
May-14-24 08:19AM Why Is Inotiv (NOTV) Stock Down 35% Today? (InvestorPlace) -49.16%
07:34AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
07:00AM Inotiv, Inc. to Report Fiscal 2024 Second Quarter Financial Results and Host Conference Call on Wednesday, May 15, 2024 (GlobeNewswire)
May-10-24 05:20AM Inotiv Delays Release of Fiscal Q2 Results (MT Newswires) -9.62%
May-09-24 06:56PM Inotiv, Inc. Reschedules its Fiscal 2024 Second Quarter Results (GlobeNewswire) -12.42%
Apr-29-24 04:05PM Inotiv, Inc. to Report Fiscal 2024 Second Quarter Financial Results and Host Conference Call on Friday, May 10, 2024 (GlobeNewswire) -7.65%
Apr-03-24 08:50AM Inotiv (NOTV) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
Apr-02-24 08:50AM Why Fast-paced Mover Inotiv (NOTV) Is a Great Choice for Value Investors (Zacks)
REVB - Revelation Biosciences Inc - Stock Price Chart
TickerREVB [NASD]
CompanyRevelation Biosciences Inc
CountryUSA
IndustryBiotechnology
Market Cap3.29MEPS (ttm)-30.78
P/E-EPS this Y-1073.58%
Forward P/E-EPS next Y15.84%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.35EPS Q/Q-104.18%
Dividend-Sales Q/Q-
Insider Own0.18%Inst Own0.47%
Insider Trans-90.44%Inst Trans-76.10%
Short Float1.09%EarningsMay 10/a
Analyst Recom1.00Target Price18.70
Avg Volume154.34K52W Range1.78 - 39.00
May-10-24 09:53PM REVB Stock Earnings: Revelation Biosciences Misses EPS for Q1 2024 (InvestorPlace) -6.36%
04:52PM Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024 (Business Wire)
Mar-22-24 09:52PM REVB Stock Earnings: Revelation Biosciences Beats EPS for Q4 2023 (InvestorPlace)
04:15PM Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023 (Business Wire)
Mar-13-24 09:00AM Revelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024) (Business Wire) -16.67%
Mar-12-24 09:00AM Revelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth Conference (Business Wire) -7.14%
Mar-04-24 09:00AM Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini (Business Wire) -6.32%
Feb-13-24 09:00AM Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024) (Business Wire) +8.70%
Feb-05-24 04:41PM Revelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering (Business Wire) +5.09%
Feb-01-24 08:27AM Why Is Revelation Biosciences (REVB) Stock Down 62% Today? (InvestorPlace) -63.86%
RDZN - Roadzen Inc - Stock Price Chart
TickerRDZN [NASD]
CompanyRoadzen Inc
CountryUSA
IndustrySoftware - Application
Market Cap234.06MEPS (ttm)0.05
P/E63.22EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-1672.89%
Dividend-Sales Q/Q-
Insider Own74.87%Inst Own8.82%
Insider Trans0.05%Inst Trans1.33%
Short Float0.10%Earnings-
Analyst Recom-Target Price-
Avg Volume17.06K52W Range2.70 - 17.00
Apr-29-24 09:20AM Dalmia Transport Selects Roadzen's DrivebuddyAI to Enhance Fleet Safety with Advanced Computer Vision (GlobeNewswire)
Mar-15-24 07:33AM Roadzen CEO Rohan Malhotra Awarded 'Innovative Entrepreneur of the Year' at the Economic Times Summit (GlobeNewswire)
Mar-05-24 08:30AM Roadzen Appoints Bruce Goldberg as General Counsel (GlobeNewswire)
Feb-12-24 04:05PM Roadzen Sets New Revenue Milestone for the Third Quarter Ended December 31, 2023 (GlobeNewswire)
Jan-08-24 08:45AM Roadzen Appoints Jean-No l Gallardo as Global Chief Financial Officer (GlobeNewswire)
Dec-05-23 08:45AM Roadzen Joins Hands with IBM, Meta, and Other Industry Leaders as a Founding Member of the AI Alliance to Advance Open, Safe, and Responsible AI (GlobeNewswire) -17.66%
Dec-01-23 07:41AM Roadzen Partners with HCLTech to deliver AI-driven auto insurance solutions for US carriers and automotive customers (GlobeNewswire)
Nov-13-23 04:05PM Roadzen Reports Record Revenue for the Second Fiscal Quarter 2024 (GlobeNewswire) -7.65%
Sep-22-23 03:05PM Maxim Group LLC to Host the Virtual Tech Conference Series: Emerging Growth in A.I., on Tuesday, September 26th & Wednesday, September 27th at 8:00 A.M. ET. (GlobeNewswire) -14.00%
Aug-28-23 09:00AM Vahanna Tech Edge Acquisition I Corporation Announces Shareholder Approval of Business Combination with Roadzen, Inc. on August 25, 2023 (GlobeNewswire) +20.73%
ECX - ECARX Holdings Inc - Stock Price Chart
TickerECX [NASD]
CompanyECARX Holdings Inc
CountryUnited Kingdom
IndustryAuto Parts
Market Cap500.34MEPS (ttm)-0.39
P/E-EPS this Y43.82%
Forward P/E-EPS next Y82.22%
PEG-EPS past 5Y-
P/S0.77EPS next 5Y-
P/B-EPS Q/Q71.33%
Dividend-Sales Q/Q18.83%
Insider Own68.62%Inst Own1.92%
Insider Trans0.00%Inst Trans0.23%
Short Float0.40%EarningsMay 20/b
Analyst Recom1.00Target Price4.82
Avg Volume72.00K52W Range1.48 - 9.34
May-03-24 07:00AM ECARX Releases Multiple Intelligent Driving Features for Skyland Pro (GlobeNewswire)
Apr-29-24 07:00AM ECARX to Report First Quarter 2024 Financial Results on May 20, 2024 (GlobeNewswire)
Apr-18-24 07:00AM ECARX Announces Strategic Partnership with FAW Group to Develop Intelligent Cockpits for Its Premium Hongqi Brand (GlobeNewswire)
Apr-10-24 04:06AM Analysis on Geely's Layout in Electrification, Connectivity, Intelligence and Sharing: Geely Forges Ahead in New Energy Era with Strategic Electrification and Technology Innovations (GlobeNewswire)
Apr-03-24 05:30PM ECARX Announces Filing of Annual Report on Form 20-F (GlobeNewswire)
Mar-28-24 07:00AM ECARX Partners with Lianyou Zhilian to Accelerate Development of Intelligent Vehicle Solutions (GlobeNewswire)
Mar-27-24 07:00AM ECARX Utilizes Microsoft Technology to Drive Innovation in Intelligent Vehicles (GlobeNewswire)
Mar-20-24 07:00AM ECARX Unveils Multiple Automotive Intelligence Solutions on Tech Day (GlobeNewswire)
Mar-04-24 07:00AM ECARX's Global Expansion Driven by Strong R&D and International Accreditations (GlobeNewswire) -7.00%
Feb-28-24 07:00AM ECARX Announces Fourth Quarter and Full Year 2023 Unaudited Financial Results (GlobeNewswire)
GVH - Globavend Holdings Ltd. - Stock Price Chart
TickerGVH [NASD]
CompanyGlobavend Holdings Ltd.
CountryAustralia
IndustryIntegrated Freight & Logistics
Market Cap24.07MEPS (ttm)0.07
P/E20.95EPS this Y33.00%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.29EPS next 5Y-
P/B-EPS Q/Q48.40%
Dividend-Sales Q/Q-10.10%
Insider Own78.25%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float0.97%Earnings-
Analyst Recom-Target Price-
Avg Volume76.80K52W Range0.79 - 5.50
Mar-18-24 03:42AM Globavend Holdings Limited Enters Into a US$20,000,000 Equity Line of Credit Facility to be Registered on Form F-1 (GlobeNewswire)
Nov-10-23 01:47PM Globavend Holdings Limited Announces Closing of its Initial Public Offering (GlobeNewswire)
Nov-07-23 04:05PM Globavend Holdings Limited Announces Pricing of Initial Public Offering (GlobeNewswire)
ZVSA - ZyVersa Therapeutics Inc - Stock Price Chart
TickerZVSA [NASD]
CompanyZyVersa Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap3.72MEPS (ttm)-75.45
P/E-EPS this Y98.62%
Forward P/E-EPS next Y-206.98%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.33EPS Q/Q-1067.67%
Dividend-Sales Q/Q-
Insider Own0.12%Inst Own11.47%
Insider Trans0.00%Inst Trans-
Short Float1.88%EarningsMay 15/b
Analyst Recom1.00Target Price70.00
Avg Volume418.65K52W Range4.44 - 180.25
May-15-24 11:53PM ZVSA Stock Earnings: ZyVersa Therapeutics Misses EPS for Q1 2024 (InvestorPlace) -6.62%
08:35AM ZyVersa Therapeutics Reports First Quarter, 2024 Financial Results and Provides Business Update (GlobeNewswire)
May-14-24 07:57AM ZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate in the 2024 BIO International Convention (GlobeNewswire)
Apr-29-24 07:57AM ZyVersa Therapeutics Announces Publication Reinforcing the Rationale for Inhibiting ASC with IC 100 to Potentially Attenuate Cardiac Comorbidities in Patients with Alzheimer's Disease (GlobeNewswire) +15.63%
Apr-04-24 07:57AM ZyVersa Therapeutics Highlights Published Data Demonstrating NLRP3 Inflammasome Inhibition Has Potential to Decrease Atherosclerotic Lesions in Patients with Diabetes (GlobeNewswire)
Mar-25-24 08:17AM ZyVersa Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Mar-18-24 07:57AM ZyVersa Therapeutics Announces IRB Approval of Phase 2a Clinical Trial Protocol to Evaluate Cholesterol Efflux Mediator VAR 200 in Patients with Diabetic Kidney Disease (GlobeNewswire) +8.79%
Mar-14-24 07:57AM ZyVersa Therapeutics' CEO, Stephen C. Glover to Participate in a Panel Discussion Titled Inflammation Illuminated, at Benzinga's Virtual Healthcare Summit 2024 on March 20, 2024 (GlobeNewswire)
Feb-29-24 07:57AM ZyVersa Therapeutics Generated Approximately $2.7 Million From Exercise of Warrants Following Excitement Around News That Inflammasome Inhibitors Have Potential to Effectively Treat Obesity (GlobeNewswire) +10.00%
Feb-28-24 07:57AM ZyVersa Therapeutics Highlights Data from Review Article Published in Nature Reinforcing IC 100's Rationale for Inhibiting ASC and ASC Specks to Attenuate Damaging Inflammation Associated with Various Conditions, Including Obesity and Its Complications (GlobeNewswire) -8.26%
CTCX - Carmell Corp - Stock Price Chart
TickerCTCX [NASD]
CompanyCarmell Corp
CountryUSA
IndustryBiotechnology
Market Cap42.64MEPS (ttm)-0.56
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S11.43EPS next 5Y-
P/B-EPS Q/Q-1833.06%
Dividend-Sales Q/Q-
Insider Own36.42%Inst Own17.57%
Insider Trans0.84%Inst Trans4.83%
Short Float0.21%Earnings-
Analyst Recom-Target Price-
Avg Volume7.46K52W Range1.70 - 13.31
May-16-24 08:54AM CTCX Stock Earnings: Carmell Therapeutics Reported Results for Q4 2023 (InvestorPlace)
Apr-11-24 04:30PM Carmell Announces Successful Closing of $3.0 Million Private Placement (GlobeNewswire) -5.60%
Apr-04-24 08:30AM Carmell Announces $3.0 Million Private Placement (GlobeNewswire) -9.72%
Mar-27-24 09:15AM Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction (GlobeNewswire) -11.03%
Mar-20-24 04:39PM Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary (GlobeNewswire) +11.84%
Mar-18-24 03:16PM Carmell to Host Investor Webinar, Unveiling the Secretome: On the Eve of Product Launch Featuring Key Opinion Leaders in the Medical Aesthetics Field (GlobeNewswire)
Feb-26-24 08:30AM Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024 (GlobeNewswire) +28.92%
Nov-16-23 08:30AM Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors (GlobeNewswire)
Sep-12-23 12:35PM Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine (PR Newswire)
Sep-05-23 06:03PM Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics (GlobeNewswire) +17.60%
1⋯1011121314151617181920
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.